IP Library › Granted Patent US 9,260,529
Granted Patent B2
US 9,260,529 · App. 13/034,144 · Granted Feb 16, 2016

Molecules that bind CD180, compositions and methods of use

Inventors: Martha Hayden-Ledbetter (Shoreline, WA); Jeffrey Ledbetter (Shoreline, WA)
Assignee: The University of Washington Through Its Center For Commercialization
C07K16/2896C12N5/0635A61K39/39541A61K39/39558C07K16/28C07K16/30C07K2317/24C07K2317/52C07K2317/54C07K2317/622C07K2317/64C07K2317/71C07K2317/73C07K2317/74C12N2501/056C12N2501/599
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,260,529
App. No.
13/034,144
Granted
Feb 16, 2016
Kind
B2
Abstract

The present invention provides novel CD180 binding molecules, methods for their identification, and methods for their use.

Claims (1)

1. An isolated anti-CD180 antibody or an antigen binding fragment thereof, comprising the complete amino acid of SEQ ID NO:2.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2016
From: CHAPLIN, JAY; HAYDEN-LEDBETTER, MARTHA; LEDBETTER, JEFFREY A.; CLARK, EDWARD A.
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 037618/0038 →
Continuity (2)
Provisional Application 61307801 · Feb 24, 2010
Related Publication 20120020965A1 · Jan 26, 2012